Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,20117,220 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Transforming Human Pancreatic Cancer Into An Immunologic Disease
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDA) is rising in incidence but remains deadly for most patients. Some progress has occurred in activating immune responses against PDA, however t...

$25.31M
USD
Completed NON-SBIR/STTR RPGS
Integration of neo-antigen vaccines and immune checkpoint therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project 1 Summary Immune-checkpoint inhibitors (ICIs) are providing durable clinical responses in about 20% of cancer patients, but have minimal effect in cancers lacking intra-tum...

Completed NON-SBIR/STTR RPGS
Mechanisms of immunomodulation with epigenetic therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project Summary/Abstract Immune checkpoint inhibitors (ICI) targeting programmed cell death protein 1 (PD-1) or its ligand have produced unprecedented clinical benefit for some can...

Completed NON-SBIR/STTR RPGS
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project Abstract – Project 3 Pancreatic ductal adenocarcinoma (PDA) is characterized by a dense desmoplastic and immunosuppressive stroma which remains a barrier to even combinatio...

Completed NON-SBIR/STTR RPGS
Integration of stromal targeting agents with immune checkpoint therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDA) is enriched with activated stellate cells and hyaluronic acids (HA) that contribute to the cancer’s poor prognosis. Our recent publication ha...

Completed NON-SBIR/STTR RPGS
Core C: Genomics and Bioinformatics
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY The Genomics and Bioinformatics Core (Core C) will provide state-of-the-art sequencing technologies to enable immunogenomic and epigenomic measurements and correspo...

Active NON-SBIR/STTR RPGS
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2027

ABSTRACT Immune checkpoint inhibitors (ICIs) are a powerful and innovative mode of cancer therapy, believed to be partially responsible for the largest single-year drop in cancer m...

$24.95M
USD
Active NON-SBIR/STTR RPGS
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

The proposed project is in the field of thoracic oncology. Lung cancer patients that get treated with radiotherapy and immunotherapy are at risk of developing serious lung side-eff...

$4.15M
USD
Completed TRAINING, INDIVIDUAL
Expanding the Druggable Human Genome
NATIONAL CANCER INSTITUTE Iowa State University United States 2021 – 2024

PROJECT SUMMARY: Most small molecule drugs elicit their effects by modulating protein function, despite the fact that only a small portion of the genome is translated (~1-2%). Furt...

$198.7K
USD
Completed NON-SBIR/STTR RPGS
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

The anti-apoptotic BCL2 family proteins (including BCL2, BCLXL, and MCL1) act by neutralizing BAX and BAK, and by inhibiting the BH3-only pro-apoptotic proteins that can activate B...

$3.8M
USD
Completed NON-SBIR/STTR RPGS
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2021 – 2026

PROJECT SUMMARY Hodgkin lymphoma (HL) is the most common (6,000 to 7,000 new cases per year) lymphoma subtype in young adulthood. Although there has been great progress during the...

$4.06M
USD
Completed NON-SBIR/STTR RPGS
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY Small cell lung cancer (SCLC) is an aggressive malignancy for which there is a critical need for improved therapeutic strategies. While targeted and immune-based th...

$5.75M
USD
Completed NON-SBIR/STTR RPGS
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project Abstract – Project 3 Pancreatic ductal adenocarcinoma (PDA) is characterized by a dense desmoplastic and immunosuppressive stroma which remains a barrier to even combinatio...

Completed NON-SBIR/STTR RPGS
Core B: Clinical Trials and Statistics
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Clinical trials and Statistics Core Project Summary The Clinical trials and Statistics Core (Core B) Resource will collaborate and provide comprehensive statistics service and infr...

Completed NON-SBIR/STTR RPGS
Core C: Genomics and Bioinformatics
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY The Genomics and Bioinformatics Core (Core C) will provide state-of-the-art sequencing technologies to enable immunogenomic and epigenomic measurements and correspo...

Completed TRAINING, INDIVIDUAL
Molecular and cancer-related roles of ACLY exon 14
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary The goal of this proposal is to understand the molecular role of alternative splicing and phosphorylation of ATP- citrate lyase (ACLY) exon 14 and how these events...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

The proposed project is in the field of thoracic oncology. Lung cancer patients that get treated with radiotherapy and immunotherapy are at risk of developing serious lung side-eff...

$2.23M
USD
Completed NON-SBIR/STTR RPGS
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Five-year survival rate of pancreatic ductal adenocarcinoma (PDAC) still remains at a dismal 10%. This poor outcome is attributed to PDAC’s complex tumor m...

$4.12M
USD
Active NON-SBIR/STTR RPGS
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2027

PROJECT SUMMARY. Cancer survivors have unique healthcare needs including risk for serious late effects, ongoing surveillance, lifestyle modifications to reduce second cancer risk,...

$1.21M
USD
Completed NON-SBIR/STTR RPGS
Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2026

ABSTRACT Compared to non-Hispanic whites, African Americans have a more than 2-fold higher incidence of multiple myeloma (MM) and its asymptomatic precursor condition, monoclonal g...

$5.86M
USD